Pacific Biosciences of California, Inc.
US ˙ NasdaqGS ˙ US69404D1081

Introducere

Această pagină oferă o analiză cuprinzătoare a istoricului cunoscut al tranzacțiilor privilegiate a Christopher Gibson. Insiders sunt ofițeri, directori sau investitori importanți într-o companie. Este ilegal ca persoanele din interior să facă tranzacții în companiile lor pe baza unor informații specifice, nepublice. Acest lucru nu înseamnă că este ilegal pentru ei să facă tranzacții în propriile companii. Cu toate acestea, ei trebuie să raporteze toate tranzacțiile către SEC printr-un Formular 4. În ciuda acestor restricții, cercetările academice sugerează că persoanele din interior - în general - tind să depășească piața în propriile companii.

Rentabilitatea medie comercială

Rentabilitatea medie a comerțului este randamentul mediu al tuturor achizițiilor de pe piața deschisă efectuate de persoane din interior în ultimii trei ani. Pentru a calcula acest lucru, examinăm fiecare achiziție neplanificată pe piață deschisă făcută de către insider, excluzând toate tranzacțiile care au fost marcate ca parte a unui plan de tranzacționare 10b5-1. Apoi calculăm performanța medie a acelor tranzacții pe 3, 6 și 12 luni, făcând o medie a fiecărei durate pentru a genera o valoare finală a performanței pentru fiecare tranzacție. În cele din urmă, facem o medie a tuturor valorilor de performanță pentru a calcula o valoare de performanță pentru persoana din interior. Această listă include doar persoane din interior care au efectuat cel puțin trei tranzacții în ultimii doi ani.

Dacă profitabilitatea acestei tranzacții este „N/A”, atunci acesta fie nu a făcut nicio achiziție pe piața deschisă în ultimii trei ani, fie tranzacțiile pe care le-au făcut sunt prea recente pentru a calcula o măsură de performanță fiabilă.

Frecvența actualizării: zilnic

Consultați lista celor mai profitabili comercianți din interior.

Companii cu poziții din interior raportate

Înregistrările SEC indică faptul că Christopher Gibson a raportat participații sau tranzacții în următoarele companii:

Securitate Titlu Ultimele participații raportate
US:RXRX / Recursion Pharmaceuticals, Inc. Director 883.735
US:PACB / Pacific Biosciences of California, Inc. Director 111.386
Cum se interpretează diagramele

Următoarele diagrame arată performanța acțiunilor de valori mobiliare ulterioare fiecărei tranzacții neplanificate pe piață deschisă efectuată de Christopher Gibson. Comerțurile neplanificate sunt tranzacții care nu au fost efectuate ca parte a unui plan de tranzacționare 10b5-1. Performanța acțiunilor este reprezentată ca variație procentuală cumulată a prețului acțiunilor. De exemplu, dacă o tranzacție privilegiată a fost efectuată la 1 ianuarie 2019, graficul va afișa modificarea procentuală zilnică a titlului până în prezent. Dacă prețul acțiunilor ar merge de la 10 USD la 15 USD în acest timp, modificarea procentuală cumulativă a prețului acțiunilor ar fi de 50%. O modificare a prețului de la 10 USD la 20 USD ar fi 100%, iar o modificare a prețului de la 10 USD la 5 USD ar fi -50%.

În cele din urmă, încercăm să determinăm cât de strâns se corelează tranzacțiile insider-ului cu randamentele în exces (pozitive sau negative) ale prețului acțiunilor, pentru a vedea dacă insider-ul își programează tranzacțiile pentru a profita de informațiile privilegiate. Luați în considerare situația în care un insider făcea asta. În această situație, ne-am aștepta fie la (a) randamente pozitive după achiziții, fie (b) la profituri negative după vânzare. În cazul punctului (a), graficul CUMPĂRĂRI ar arăta o serie de curbe în pantă ascendentă, indicând randamente pozitive după fiecare tranzacție de cumpărare. În cazul (b), graficul VÂNZARE ar arăta o serie de curbe înclinate în jos, indicând randamente negative după fiecare tranzacție de vânzare.

Cu toate acestea, acest lucru în sine nu este suficient pentru a trage concluzii. Dacă, de exemplu, prețul acțiunilor companiei a fost într-o creștere neciclică de-a lungul multor ani, atunci ne-am aștepta ca toate parcelele post-cumpărare să fie în pantă ascendentă. De asemenea, scăderile non-ciclice de-a lungul multor ani ar avea ca rezultat o pantă descendentă post-tranzacționare. Niciunul dintre aceste grafice nu ar sugera activitate de tranzacționare a informațiilor privilegiate.

Cel mai puternic indicator ar fi o situație în care prețul acțiunilor a fost extrem de ciclic, și au existat atât semnale pozitive în graficul CUMPĂRARE, cât și grafice negative pe graficul VÂNZARE. Această situație ar sugera foarte mult un insider care a programat tranzacțiile în avantajul lor financiar.

Achiziții din interior PACB / Pacific Biosciences of California, Inc. - Analiza profitului pe termen scurt

În această secțiune, analizăm profitabilitatea fiecărei achiziții neplanificate, pe piață deschisă, efectuată în PACB / Pacific Biosciences of California, Inc.. Această analiză ajută la înțelegerea dacă persoana din interior generează în mod constant profituri anormale și merită urmărită. Această analiză este pentru un an după fiecare tranzacție, iar rezultatele sunt teoretice .

Următorul tabel prezintă cele mai recente achiziții pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Ticker Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Max
Pret la
Max
Max
Profit ($)
Randament maxim (%)
Nu se cunosc tranzacții neplanificate pe piața deschisă pentru această combinație de informații privilegiate și de securitate

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate sunt acțiunile ajustate în funcție de divizarea.

PACB / Pacific Biosciences of California, Inc. Insider Trades
Vânzări din interior PACB / Pacific Biosciences of California, Inc. - Analiza pierderilor pe termen scurt

În această secțiune, analizăm evitarea pierderilor pe termen scurt a fiecărei vânzări neplanificate, pe piață deschisă, efectuată în PACB / Pacific Biosciences of California, Inc.. Un model consistent de evitare a pierderilor poate sugera că viitoarele tranzacții de vânzare pot prezice scăderi ale prețului. Această analiză este pentru un an după fiecare tranzacție, iar rezultatele sunt teoretice .

Următorul tabel arată cele mai recente vânzări pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Ticker Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Min
Pret la
Min
Pierdere maximă
Evitat ($)
Pierdere maximă
Evitat (%)
Nu se cunosc tranzacții neplanificate pe piața deschisă pentru această combinație de informații privilegiate și de securitate

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate sunt acțiunile ajustate în funcție de divizarea.

PACB / Pacific Biosciences of California, Inc. Insider Trades
Achiziții din interior RXRX / Recursion Pharmaceuticals, Inc. - Analiza profitului pe termen scurt

În această secțiune, analizăm profitabilitatea fiecărei achiziții neplanificate, pe piață deschisă, efectuată în PACB / Pacific Biosciences of California, Inc.. Această analiză ajută la înțelegerea dacă persoana din interior generează în mod constant profituri anormale și merită urmărită. Această analiză este pentru un an după fiecare tranzacție, iar rezultatele sunt teoretice .

Următorul tabel prezintă cele mai recente achiziții pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Ticker Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Max
Pret la
Max
Max
Profit ($)
Randament maxim (%)
Nu se cunosc tranzacții neplanificate pe piața deschisă pentru această combinație de informații privilegiate și de securitate

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate sunt acțiunile ajustate în funcție de divizarea.

RXRX / Recursion Pharmaceuticals, Inc. Insider Trades
Vânzări din interior RXRX / Recursion Pharmaceuticals, Inc. - Analiza pierderilor pe termen scurt

În această secțiune, analizăm evitarea pierderilor pe termen scurt a fiecărei vânzări neplanificate, pe piață deschisă, efectuată în PACB / Pacific Biosciences of California, Inc.. Un model consistent de evitare a pierderilor poate sugera că viitoarele tranzacții de vânzare pot prezice scăderi ale prețului. Această analiză este pentru un an după fiecare tranzacție, iar rezultatele sunt teoretice .

Următorul tabel arată cele mai recente vânzări pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Ticker Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Min
Pret la
Min
Pierdere maximă
Evitat ($)
Pierdere maximă
Evitat (%)
2022-03-15 RXRX Gibson Christopher 6.150 6,0825 6.150 6,0825 37.407 57 5.0400 -6.411 -17,14
2022-03-14 RXRX Gibson Christopher 230.000 6,2818 230.000 6,2818 1.444.814
2022-03-11 RXRX Gibson Christopher 100.000 6,9458 100.000 6,9458 694.580
2022-03-07 RXRX Gibson Christopher 300.000 7,2965 300.000 7,2965 2.188.950
2022-02-22 RXRX Gibson Christopher 100.000 10,2154 100.000 10,2154 1.021.540
2022-01-31 RXRX Gibson Christopher 19.858 11,7315 19.858 11,7315 232.964
2022-01-14 RXRX Gibson Christopher 254.000 13,5654 254.000 13,5654 3.445.612
2022-01-13 RXRX Gibson Christopher 78.206 14,2571 78.206 14,2571 1.114.991
2022-01-13 RXRX Gibson Christopher 8.794 14,9619 8.794 14,9619 131.575

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate sunt acțiunile ajustate în funcție de divizarea.

RXRX / Recursion Pharmaceuticals, Inc. Insider Trades
Istoricul tranzacțiilor privilegiate

Acest tabel arată lista completă a tranzacțiilor privilegiate efectuate de Christopher Gibson, astfel cum a fost dezvăluită Comisiei pentru Bursa de Valori Valori (SEC).

Data fișierului Tran Data Formă Ticker Securitate Cod 10b5-1 Acțiuni Acțiuni rămase La sută
Schimbare
Acțiune
Preț
Tran
Valoare
Rămas
Valoare
2026-06-05 2026-06-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -40.000 883.735 -4,33 3,62 -144.800 3.199.121
2026-06-05 2026-06-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 40.000 923.735 4,53
2026-05-27 2026-05-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -40.000 883.735 -4,33 3,08 -123.200 2.721.904
2026-05-27 2026-05-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 40.000 923.735 4,53
2026-05-19 2026-05-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes -22.821 883.735 -2,52 3,04 -69.376 2.686.554
2026-05-08 2026-05-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -20.000 906.556 -2,16
2026-05-08 2026-05-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -40.000 926.556 -4,14 3,37 -134.800 3.122.494
2026-05-08 2026-05-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 60.000 966.556 6,62
2026-04-24 2026-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -40.000 906.556 -4,23 3,61 -144.400 3.272.667
2026-04-24 2026-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 40.000 946.556 4,41
2026-04-10 2026-04-08 4 PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Common Stock
A - Award 57.473 111.386 106,60
2026-04-08 2026-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -40.000 906.556 -4,23 3,10 -124.000 2.810.324
2026-04-08 2026-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 40.000 946.556 4,41
2026-03-25 2026-03-23 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -40.000 906.556 -4,23 3,25 -130.000 2.946.307
2026-03-25 2026-03-23 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 40.000 946.556 4,41
2026-03-11 2026-03-09 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -20.000 906.556 -2,16
2026-03-11 2026-03-09 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 926.556 2,21
2026-03-05 2026-03-03 4 PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Common Stock
A - Award 53.913 53.913
2026-02-19 2026-02-19 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -40.000 906.556 -4,23 3,46 -138.400 3.136.684
2026-02-19 2026-02-19 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 40.000 946.556 4,41
2026-02-19 2026-02-17 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes -27.265 906.556 -2,92 3,49 -95.155 3.163.880
2026-02-06 2026-02-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes -10.364 933.821 -1,10 3,56 -36.896 3.324.403
2026-02-06 2026-02-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
A - Award 30.346 944.185 3,32
2026-02-06 2026-02-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -40.000 913.839 -4,19 4,12 -164.800 3.765.017
2026-02-06 2026-02-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 40.000 953.839 4,38
2026-01-22 2026-01-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -40.000 913.839 -4,19 4,47 -178.800 4.084.860
2026-01-22 2026-01-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 40.000 953.839 4,38
2026-01-07 2026-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -20.000 913.839 -2,14
2026-01-07 2026-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -40.000 933.839 -4,11 4,25 -170.000 3.968.816
2026-01-07 2026-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 60.000 973.839 6,57
2025-12-19 2025-12-19 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -40.000 913.839 -4,19 4,50 -180.000 4.112.276
2025-12-19 2025-12-19 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 40.000 953.839 4,38
2025-12-05 2025-12-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -20.000 913.839 -2,14
2025-12-05 2025-12-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -40.000 933.839 -4,11 4,63 -185.200 4.323.675
2025-12-05 2025-12-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 60.000 973.839 6,57
2025-11-19 2025-11-19 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -40.000 913.839 -4,19 4,16 -166.400 3.801.570
2025-11-19 2025-11-19 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 40.000 953.839 4,38
2025-11-19 2025-11-17 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes -40.390 913.839 -4,23 4,14 -167.215 3.783.293
2025-11-06 2025-11-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -20.000 954.229 -2,05
2025-11-06 2025-11-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -40.000 974.229 -3,94 5,21 -208.400 5.075.733
2025-11-06 2025-11-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 60.000 1.014.229 6,29
2025-10-24 2025-10-23 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -100.000 954.229 -9,49 5,70 -570.000 5.439.105
2025-10-24 2025-10-23 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 100.000 1.054.229 10,48
2025-10-10 2025-10-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -20.000 954.229 -2,05
2025-10-10 2025-10-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -100.000 974.229 -9,31 6,04 -604.000 5.884.343
2025-10-10 2025-10-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 120.000 1.074.229 12,58
2025-09-26 2025-09-25 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -100.000 954.229 -9,49 4,76 -476.000 4.542.130
2025-09-26 2025-09-25 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 100.000 1.054.229 10,48
2025-09-12 2025-09-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -20.000 954.229 -2,05
2025-09-12 2025-09-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -100.000 974.229 -9,31 4,71 -471.000 4.588.619
2025-09-12 2025-09-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 120.000 1.074.229 12,58
2025-08-28 2025-08-26 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -100.000 954.229 -9,49 4,84 -484.000 4.618.468
2025-08-28 2025-08-26 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 100.000 1.054.229 10,48
2025-08-19 2025-08-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes -40.390 954.229 -4,06 5,64 -227.800 5.381.852
2025-08-13 2025-08-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -17.875 0 -100,00 5,28 -94.380
2025-08-13 2025-08-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 17.875 17.875
2025-08-13 2025-08-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -100.000 0 -100,00 5,28 -528.000
2025-08-13 2025-08-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 100.000 100.000
2025-08-13 2025-08-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -10.000 994.619 -1,00
2025-08-13 2025-08-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500.300 1.004.619 -33,24 5,28 -2.641.584 5.304.388
2025-08-13 2025-08-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 423.666 1.504.919 39,18
2025-05-19 2025-05-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes -36.197 1.081.253 -3,24 4,25 -153.837 4.595.325
2025-03-28 2025-03-27 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -138.574 1.117.450 -11,03 6,04 -836.987 6.749.398
2025-03-07 2025-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -20.000 1.256.024 -1,57 6,37 -127.400 8.000.873
2025-03-07 2025-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 1.276.024 1,59
2025-03-07 2025-03-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -20.000 1.256.024 -1,57 6,58 -131.600 8.264.638
2025-03-07 2025-03-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 1.276.024 1,59
2025-02-20 2025-02-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes -17.132 1.256.024 -1,35 10,64 -182.284 13.364.095
2025-02-07 2025-02-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -20.000 1.273.156 -1,55 8,12 -162.400 10.338.027
2025-02-07 2025-02-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 1.293.156 1,57
2025-02-07 2025-02-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -20.000 1.273.156 -1,55 7,68 -153.600 9.777.838
2025-02-07 2025-02-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 1.293.156 1,57
2025-02-05 2025-02-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes -5.569 1.273.156 -0,44 7,25 -40.375 9.230.381
2025-02-05 2025-02-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
A - Award 16.809 1.278.725 1,33
2025-02-05 2025-02-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
A - Award 525.283 1.261.916 71,31
2025-01-13 2025-01-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -20.000 736.633 -2,64 7,05 -141.000 5.193.263
2025-01-13 2025-01-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 756.633 2,72
2025-01-13 2025-01-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -20.000 736.633 -2,64 7,31 -146.200 5.384.787
2025-01-13 2025-01-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 756.633 2,72
2024-12-06 2024-12-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -20.000 736.633 -2,64 7,12 -142.400 5.244.827
2024-12-06 2024-12-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 756.633 2,72
2024-12-06 2024-12-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -20.000 736.633 -2,64 7,16 -143.200 5.274.292
2024-12-06 2024-12-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 756.633 2,72
2024-11-19 2024-11-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes -26.023 736.633 -3,41 6,18 -160.692 4.548.709
2024-11-15 2024-11-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -20.000 762.656 -2,56 7,35 -147.000 5.605.522
2024-11-15 2024-11-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 782.656 2,62
2024-11-15 2024-11-13 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -20.000 762.656 -2,56 7,74 -154.800 5.902.957
2024-11-15 2024-11-13 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 782.656 2,62
2024-10-04 2024-10-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -20.000 762.656 -2,56 6,08 -121.600 4.636.948
2024-10-04 2024-10-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 782.656 2,62
2024-10-04 2024-10-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -20.000 762.656 -2,56 6,16 -123.200 4.697.961
2024-10-04 2024-10-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 782.656 2,62
2024-09-06 2024-09-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -20.000 762.656 -2,56 6,14 -122.800 4.682.708
2024-09-06 2024-09-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 782.656 2,62
2024-09-06 2024-09-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -20.000 762.656 -2,56 6,04 -120.800 4.606.442
2024-09-06 2024-09-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 782.656 2,62
2024-08-30 2024-08-30 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise 5.000 762.656 0,66 2,48 12.400 1.891.387
2024-08-29 2024-08-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise 5.000 757.656 0,66 2,48 12.400 1.878.987
2024-08-28 2024-08-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise 5.000 752.656 0,67 2,48 12.400 1.866.587
2024-08-27 2024-08-27 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise 5.000 747.656 0,67 2,48 12.400 1.854.187
2024-08-26 2024-08-26 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise 5.000 742.656 0,68 2,48 12.400 1.841.787
2024-08-23 2024-08-23 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise 5.000 737.656 0,68 2,48 12.400 1.829.387
2024-08-19 2024-08-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes -26.082 732.656 -3,44 6,69 -174.489 4.901.469
2024-08-09 2024-08-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -20.000 758.738 -2,57 6,50 -130.000 4.931.797
2024-08-09 2024-08-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 778.738 2,64
2024-08-09 2024-08-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -30.000 758.738 -3,80 7,10 -213.000 5.387.040
2024-08-09 2024-08-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 30.000 788.738 3,95
2024-07-12 2024-06-05 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 100.000 908.738 12,36
2024-07-12 2024-07-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -50.000 758.738 -6,18 7,47 -373.500 5.667.773
2024-07-12 2024-07-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 50.000 808.738 6,59
2024-07-12 2024-07-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -50.000 758.738 -6,18 7,48 -374.000 5.675.360
2024-07-12 2024-07-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 50.000 808.738 6,59
2024-07-12 2024-07-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -25.000 758.738 -3,19
2024-06-07 2024-06-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -50.000 708.738 -6,59 9,00 -450.000 6.378.642
2024-06-07 2024-06-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -50.000 758.738 -6,18 8,42 -421.000 6.388.574
2024-06-07 2024-06-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -25.000 808.738 -3,00
2024-06-07 2024-06-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 25.000 833.738 3,09
2024-05-17 2024-05-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes -26.082 808.738 -3,12 10,01 -261.081 8.095.467
2024-05-03 2024-05-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -21.296 834.820 -2,49 8,47 -180.377 7.070.925
2024-05-03 2024-05-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 21.296 856.116 2,55
2024-05-03 2024-05-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -28.704 834.820 -3,32 8,47 -243.123 7.070.925
2024-05-03 2024-05-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -50.000 863.524 -5,47 7,73 -386.500 6.675.041
2024-05-03 2024-05-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -25.000 913.524 -2,66
2024-04-05 2024-04-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -25.000 0 -100,00 9,02 -225.500
2024-04-05 2024-04-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 25.000 25.000
2024-04-05 2024-04-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -40.000 938.524 -4,09 9,02 -360.800 8.465.486
2024-04-05 2024-04-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -25.000 0 -100,00 8,84 -221.000
2024-04-05 2024-04-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 25.000 25.000
2024-04-05 2024-04-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -40.000 978.524 -3,93 8,84 -353.600 8.650.152
2024-04-05 2024-04-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -25.000 1.018.524 -2,40
2024-04-01 2024-03-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -25.000 0 -100,00 10,10 -252.500
2024-04-01 2024-03-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 25.000 25.000
2024-04-01 2024-03-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -40.000 1.043.524 -3,69 10,10 -404.000 10.539.592
2024-04-01 2024-03-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -25.000 1.083.524 -2,26
2024-03-08 2024-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 11,56 -11.562
2024-03-08 2024-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2024-03-08 2024-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -20.000 0 -100,00 11,55 -231.002
2024-03-08 2024-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 20.000
2024-03-08 2024-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -4.000 0 -100,00 11,56 -46.259
2024-03-08 2024-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 4.000 4.000
2024-03-08 2024-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -36.319 1.108.524 -3,17 11,86 -430.682 13.145.210
2024-03-08 2024-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 8.674 1.144.843 0,76 11,40 98.884 13.051.210
2024-03-08 2024-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31.250 1.136.169 2,83 2,48 77.500 2.817.699
2024-03-08 2024-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -10.000 1.104.919 -0,90
2024-03-08 2024-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 10.000 1.114.919 0,91
2024-02-16 2024-02-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes -11.148 1.104.919 -1,00 12,43 -138.570 13.734.143
2024-02-13 2024-02-09 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes -3.233 1.116.067 -0,29 10,09 -32.621 11.261.116
2024-02-13 2024-02-09 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
A - Award 333.449 1.119.300 42,43
2024-02-13 2024-02-09 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
A - Award 11.148 785.851 1,44
2024-02-09 2024-02-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -48.272 774.703 -5,87 9,22 -444.981 7.141.367
2024-02-09 2024-02-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31.250 822.975 3,95 2,48 77.500 2.040.978
2024-02-09 2024-02-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -10.000 791.725 -1,25
2024-02-09 2024-02-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 10.000 801.725 1,26
2024-01-05 2024-01-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 9,49 -9.494
2024-01-05 2024-01-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2024-01-05 2024-01-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -20.000 0 -100,00 9,51 -190.240
2024-01-05 2024-01-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 20.000
2024-01-05 2024-01-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -4.000 0 -100,00 9,51 -38.029
2024-01-05 2024-01-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 4.000 4.000
2024-01-05 2024-01-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -30.853 791.725 -3,75 9,49 -292.804 7.513.708
2024-01-05 2024-01-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31.250 822.578 3,95 2,48 77.500 2.039.993
2024-01-05 2024-01-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -10.000 791.328 -1,25
2024-01-05 2024-01-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 10.000 801.328 1,26
2023-12-08 2023-12-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -59.829 791.328 -7,03 7,49 -448.394 5.930.687
2023-12-08 2023-12-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31.250 851.157 3,81 2,48 77.500 2.110.869
2023-12-08 2023-12-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -10.000 819.907 -1,20
2023-12-08 2023-12-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 10.000 829.907 1,22
2023-11-17 2023-11-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes -16.913 819.907 -2,02 7,18 -121.435 5.886.932
2023-11-17 2023-11-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -10.000 836.820 -1,18
2023-11-17 2023-11-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 10.000 846.820 1,20
2023-11-03 2023-11-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 5,14 -5.137
2023-11-03 2023-11-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2023-11-03 2023-11-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -20.000 0 -100,00 5,11 -102.294
2023-11-03 2023-11-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 20.000
2023-11-03 2023-11-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -4.000 0 -100,00 5,14 -20.564
2023-11-03 2023-11-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 4.000 4.000
2023-11-03 2023-11-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -37.177 836.820 -4,25 5,20 -193.306 4.351.129
2023-11-03 2023-11-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31.250 873.997 3,71 2,48 77.500 2.167.513
2023-10-18 2023-10-16 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -10.000 842.747 -1,17
2023-10-18 2023-10-16 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 10.000 852.747 1,19
2023-10-06 2023-10-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -59.794 842.747 -6,63 7,21 -431.025 6.074.942
2023-10-06 2023-10-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31.250 902.541 3,59 2,48 77.500 2.238.302
2023-09-19 2023-09-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -10.000 871.291 -1,13
2023-09-19 2023-09-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 10.000 881.291 1,15
2023-09-08 2023-09-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 8,84 -8.836
2023-09-08 2023-09-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2023-09-08 2023-09-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -20.000 0 -100,00 8,83 -176.696
2023-09-08 2023-09-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 20.000
2023-09-08 2023-09-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -4.000 0 -100,00 8,83 -35.335
2023-09-08 2023-09-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 4.000 4.000
2023-09-08 2023-09-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -33.765 871.291 -3,73 8,78 -296.575 7.652.984
2023-09-08 2023-09-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31.250 905.056 3,58 2,48 77.500 2.244.539
2023-08-17 2023-08-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes -16.913 873.806 -1,90 9,19 -155.430 8.030.277
2023-08-11 2023-08-09 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -10.000 890.719 -1,11
2023-08-11 2023-08-09 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 10.000 900.719 1,12
2023-08-04 2023-08-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -4.060 890.719 -0,45 13,36 -54.254 11.902.767
2023-08-04 2023-08-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -60.955 894.779 -6,38 13,02 -793.457 11.647.428
2023-08-04 2023-08-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31.250 955.734 3,38 2,48 77.500 2.370.220
2023-08-04 2023-08-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 8.674 924.484 0,95 11,40 98.884 10.539.118
2023-07-21 2023-07-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -10.000 915.810 -1,08
2023-07-21 2023-07-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 10.000 925.810 1,09
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -13 0 -100,00 14,85 -193
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -63 13 -82,89 13,75 -867 179
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -127 76 -62,56 12,36 -1.569 939
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -561 203 -73,43 11,82 -6.634 2.400
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -236 764 -23,60 10,87 -2.565 8.305
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -550 0 -100,00 14,03 -7.716
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -4.693 550 -89,51 12,41 -58.255 6.827
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -10.327 5.243 -66,33 11,74 -121.282 61.575
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -4.430 15.570 -22,15 10,84 -48.013 168.751
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 20.000
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -127 0 -100,00 14,06 -1.786
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -850 127 -87,00 12,41 -10.546 1.576
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -2.173 977 -68,98 11,80 -25.642 11.529
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -850 3.150 -21,25 10,82 -9.198 34.085
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 4.000 4.000
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -17.227 915.810 -1,85 14,34 -247.104 13.136.379
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -3.270 933.037 -0,35 12,39 -40.506 11.557.809
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -7.898 936.307 -0,84 11,80 -93.172 11.045.520
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -3.423 944.205 -0,36 10,87 -37.194 10.259.543
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31.250 947.628 3,41 2,48 77.500 2.350.117
2023-06-16 2023-06-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -10.000 916.378 -1,08
2023-06-16 2023-06-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 10.000 926.378 1,09
2023-06-09 2023-06-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -56.436 916.378 -5,80 9,05 -510.808 8.294.229
2023-06-09 2023-06-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31.250 972.814 3,32 2,48 77.500 2.412.579
2023-05-17 2023-05-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes -11.661 941.564 -1,22 5,60 -65.302 5.272.758
2023-05-05 2023-05-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 4,92 -4.915
2023-05-05 2023-05-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2023-05-05 2023-05-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -20.000 0 -100,00 4,90 -98.036
2023-05-05 2023-05-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 20.000
2023-05-05 2023-05-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -4.000 0 -100,00 4,91 -19.623
2023-05-05 2023-05-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 4.000 4.000
2023-05-05 2023-05-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -33.073 953.225 -3,35 4,71 -155.761 4.489.308
2023-05-05 2023-05-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31.250 986.298 3,27 2,48 77.500 2.446.019
2023-05-05 2023-05-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -1.338 955.048 -0,14
2023-05-05 2023-05-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.338 956.386 0,14
2023-05-05 2023-05-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -8.662 955.048 -0,90
2023-05-05 2023-03-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -3.000 963.710 -0,31
2023-05-05 2023-03-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 3.000 966.710 0,31
2023-05-05 2023-02-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -3.000 963.710 -0,31
2023-05-05 2023-02-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 3.000 966.710 0,31
2023-05-05 2023-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -3.000 963.710 -0,31
2023-05-05 2023-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 3.000 966.710 0,31
2023-04-28 2022-12-14 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -3.000 582.805 -0,51
2023-04-28 2022-12-14 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 3.000 585.805 0,51
2023-04-28 2022-11-16 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -3.000 582.805 -0,51
2023-04-28 2022-11-16 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 3.000 585.805 0,51
2023-04-28 2022-10-19 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -3.000 582.805 -0,51
2023-04-28 2022-10-19 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 3.000 585.805 0,51
2023-04-28 2022-09-19 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -3.000 582.805 -0,51
2023-04-28 2022-09-19 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 3.000 585.805 0,51
2023-04-28 2022-08-17 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -3.000 582.805 -0,51
2023-04-28 2022-08-17 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 3.000 585.805 0,51
2023-04-28 2022-07-19 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -3.000 582.805 -0,51
2023-04-28 2022-07-19 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 3.000 585.805 0,51
2023-04-28 2022-06-21 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -3.000 582.805 -0,51
2023-04-28 2022-06-21 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 3.000 585.805 0,51
2023-04-28 2022-05-19 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -12.000 582.805 -2,02
2023-04-28 2022-05-19 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 12.000 594.805 2,06
2023-04-28 2022-05-12 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -12.000 582.805 -2,02
2023-04-28 2022-05-12 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 12.000 594.805 2,06
2023-04-28 2022-04-25 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -12.000 582.805 -2,02
2023-04-28 2022-04-25 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 12.000 594.805 2,06
2023-04-28 2022-01-05 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 582.805 -3,08 7,39 -136.669 4.305.472
2023-04-28 2022-01-05 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 601.305 3,17
2023-04-07 2023-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -40.000 906.710 -4,23 6,64 -265.672 6.022.186
2023-04-07 2023-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -13.327 946.710 -1,39 6,46 -86.038 6.111.865
2023-04-07 2023-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31.250 960.037 3,36 2,48 77.500 2.380.892
2023-04-07 2023-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -10.000 928.787 -1,07
2023-03-15 2023-03-13 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -3.000 938.787 -0,32
2023-03-15 2023-03-13 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 3.000 941.787 0,32
2023-03-10 2023-03-09 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -15.000 938.787 -1,57 7,77 -116.620 7.298.787
2023-03-10 2023-03-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 8,09 -8.087
2023-03-10 2023-03-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2023-03-10 2023-03-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -20.000 0 -100,00 8,10 -161.900
2023-03-10 2023-03-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20.000 20.000
2023-03-10 2023-03-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -4.000 0 -100,00 8,09 -32.362
2023-03-10 2023-03-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 4.000 4.000
2023-03-10 2023-03-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -10.000 953.787 -1,04
2023-03-10 2023-03-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -70.890 963.787 -6,85 8,10 -573.925 7.802.820
2023-03-10 2023-03-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 93.750 1.034.677 9,96 2,48 232.500 2.565.999
2023-03-06 2023-03-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 7,91 -7.909
2023-03-06 2023-03-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2023-03-06 2023-03-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2023-03-06 2023-03-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 7,91 -7.906
2023-03-06 2023-03-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500 0 -100,00 7,90 -3.952
2023-03-06 2023-03-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2023-03-06 2023-03-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 940.927 -1,93 7,92 -146.502 7.451.201
2023-03-06 2023-03-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 956.427 1,97
2023-02-17 2023-02-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes -1.346 940.927 -0,14 8,44 -11.360 7.941.424
2023-02-03 2023-02-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 9,20 -9.202
2023-02-03 2023-02-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2023-02-03 2023-02-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2023-02-03 2023-02-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 9,21 -9.208
2023-02-03 2023-02-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500 0 -100,00 9,21 -4.604
2023-02-03 2023-02-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2023-02-03 2023-02-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 942.273 -1,93 9,22 -170.548 8.686.626
2023-02-03 2023-02-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 960.773 1,96
2023-02-03 2023-02-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes -1.382 942.273 -0,15 8,55 -11.816 8.056.434
2023-02-03 2023-02-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
A - Award 11.050 943.655 1,18
2023-02-03 2023-02-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
A - Award 406.800 932.605 77,37
2023-01-06 2023-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 7,38 -7.382
2023-01-06 2023-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2023-01-06 2023-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2023-01-06 2023-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 7,39 -7.391
2023-01-06 2023-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500 0 -100,00 7,38 -3.689
2023-01-06 2023-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2023-01-06 2023-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 525.805 -3,40 7,39 -136.669 3.884.384
2023-01-06 2023-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 544.305 3,52
2023-01-06 2022-12-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -3.000 525.805 -0,57
2023-01-06 2022-11-16 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -3.000 528.805 -0,56
2023-01-06 2022-10-19 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -3.000 531.805 -0,56
2023-01-06 2022-09-19 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -3.000 534.805 -0,56
2023-01-06 2022-08-17 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -3.000 537.805 -0,55
2023-01-06 2022-07-19 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -3.000 540.805 -0,55
2023-01-06 2022-06-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -3.000 543.805 -0,55
2023-01-06 2022-05-19 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -12.000 546.805 -2,15
2023-01-06 2022-05-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -12.000 558.805 -2,10
2023-01-06 2022-04-25 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -12.000 570.805 -2,06
2022-12-02 2022-12-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 9,28 -9.277
2022-12-02 2022-12-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 9,28 -9.277
2022-12-02 2022-12-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-12-02 2022-12-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-12-02 2022-12-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500 0 -100,00 9,26 -4.632
2022-12-02 2022-12-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-12-02 2022-12-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 582.805 -3,08 9,28 -171.615 5.406.391
2022-12-02 2022-12-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 601.305 3,17
2022-12-02 2022-12-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.710 582.805 -3,11 8,77 -164.145 5.113.007
2022-12-02 2022-12-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31.250 601.515 5,48 2,48 77.500 1.491.757
2022-11-17 2022-11-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes -5.751 570.265 -1,00 11,86 -68.207 6.763.343
2022-11-04 2022-11-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 10,10 -10.099
2022-11-04 2022-11-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-11-04 2022-11-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-11-04 2022-11-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 10,10 -10.098
2022-11-04 2022-11-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500 0 -100,00 10,11 -5.055
2022-11-04 2022-11-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-11-04 2022-11-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 576.016 -3,11 10,11 -187.037 5.823.579
2022-11-04 2022-11-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 594.516 3,21
2022-11-04 2022-11-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.193 576.016 -3,06 9,89 -179.911 5.696.222
2022-11-04 2022-11-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31.250 594.209 5,55 2,48 77.500 1.473.638
2022-10-07 2022-10-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 11,64 -11.641
2022-10-07 2022-10-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-10-07 2022-10-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-10-07 2022-10-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 11,64 -11.643
2022-10-07 2022-10-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500 0 -100,00 11,64 -5.821
2022-10-07 2022-10-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-10-07 2022-10-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 562.959 -3,18 11,65 -215.551 6.559.260
2022-10-07 2022-10-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 581.459 3,29
2022-10-07 2022-10-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -17.553 562.959 -3,02 11,50 -201.917 6.475.886
2022-10-07 2022-10-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31.250 580.512 5,69 2,48 77.500 1.439.670
2022-09-02 2022-09-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 10,50 -10.504
2022-09-02 2022-09-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-09-02 2022-09-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-09-02 2022-09-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 10,50 -10.502
2022-09-02 2022-09-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500 0 -100,00 10,50 -5.249
2022-09-02 2022-09-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-09-02 2022-09-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 549.262 -3,26 10,49 -194.041 5.761.044
2022-09-02 2022-09-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 567.762 3,37
2022-09-02 2022-09-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.066 549.262 -3,18 10,18 -183.903 5.591.213
2022-09-02 2022-09-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31.250 567.328 5,83 2,48 77.500 1.406.973
2022-08-17 2022-08-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes -5.751 536.078 -1,06 12,96 -74.533 6.947.571
2022-08-05 2022-08-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 9,45 -9.447
2022-08-05 2022-08-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-08-05 2022-08-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-08-05 2022-08-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 9,45 -9.448
2022-08-05 2022-08-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500 0 -100,00 9,44 -4.722
2022-08-05 2022-08-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-08-05 2022-08-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 541.829 -3,30 9,45 -174.879 5.121.855
2022-08-05 2022-08-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 560.329 3,41
2022-08-05 2022-08-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.325 541.829 -3,27 9,53 -174.562 5.161.409
2022-08-05 2022-08-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31.250 560.154 5,91 2,48 77.500 1.389.182
2022-07-08 2022-07-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 9,07 -9.068
2022-07-08 2022-07-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-07-08 2022-07-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-07-08 2022-07-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 9,07 -9.070
2022-07-08 2022-07-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500 0 -100,00 9,06 -4.531
2022-07-08 2022-07-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-07-08 2022-07-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 528.904 -3,38 9,07 -167.745 4.795.731
2022-07-08 2022-07-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 547.404 3,50
2022-07-08 2022-07-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.614 528.904 -3,40 9,04 -168.233 4.780.234
2022-07-08 2022-07-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31.250 547.518 6,05 2,48 77.500 1.357.845
2022-06-06 2022-06-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 6,34 -6.341
2022-06-06 2022-06-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-06-06 2022-06-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-06-06 2022-06-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 6,35 -6.346
2022-06-06 2022-06-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500 0 -100,00 6,34 -3.172
2022-06-06 2022-06-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-06-06 2022-06-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 516.268 -3,46 6,34 -117.381 3.275.669
2022-06-06 2022-06-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 534.768 3,58
2022-06-06 2022-06-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -21.190 516.268 -3,94 5,87 -124.385 3.030.493
2022-06-06 2022-06-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31.250 537.458 6,17 2,48 77.500 1.332.896
2022-05-18 2022-05-16 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes X -5.764 506.208 -1,13 5,67 -32.682 2.870.199
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 134.875 -0,74
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 134.875 -0,74
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -500 544.000 -0,09
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -18.500 6.806.834 -0,27
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 6,44 -6.439
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 6,43 -6.435
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500 0 -100,00 6,44 -3.221
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 511.972 -3,49 6,44 -119.118 3.296.485
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 530.472 3,61
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 135.875 -0,73
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 135.875 -0,73
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -500 544.500 -0,09
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -31.250 1.000.000 -3,03
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -18.500 6.825.334 -0,27
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 6,47 -6.474
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 6,48 -6.481
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500 0 -100,00 6,47 -3.235
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 511.972 -3,49 6,48 -119.852 3.316.811
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 530.472 3,61
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -13.330 511.972 -2,54 6,50 -86.645 3.327.818
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31.250 525.302 6,33 2,48 77.500 1.302.749
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 136.875 -0,73
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 136.875 -0,73
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -500 545.000 -0,09
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -44.010 1.031.250 -4,09
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -18.500 6.843.834 -0,27
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 6,31 -6.308
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 6,30 -6.304
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500 0 -100,00 6,31 -3.156
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 494.052 -3,61 6,30 -116.576 3.113.219
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 512.552 3,74
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -19.570 494.052 -3,81 6,07 -118.757 2.998.056
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 44.014 513.622 9,37 2,48 109.155 1.273.783
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 137.875 -0,72
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 137.875 -0,72
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -500 545.500 -0,09
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -44.010 1.075.264 -3,93
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -18.500 6.862.334 -0,27
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 6,07 -6.070
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 6,07 -6.069
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500 0 -100,00 6,05 -3.026
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 469.608 -3,79 6,08 -112.545 2.856.860
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 488.108 3,94
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -19.105 469.608 -3,91 6,10 -116.571 2.865.360
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 44.010 488.713 9,90 2,48 109.145 1.212.008
2022-04-25 2022-04-25 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Commo Stock
C - Conversion X -12.000 6.880.834 -0,17
2022-04-25 2022-04-25 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X -12.000 444.703 -2,63
2022-04-25 2022-04-25 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 12.000 456.703 2,70
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 138.875 -0,71
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 138.875 -0,71
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -500 546.000 -0,09
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -44.010 1.119.274 -3,78
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -18.500 6.892.834 -0,27
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 6,00 -6.005
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 6,01 -6.006
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500 0 -100,00 5,99 -2.995
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 444.703 -3,99 6,00 -111.080 2.670.130
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 463.203 4,16
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -19.453 444.703 -4,19 6,07 -118.095 2.699.703
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 44.010 464.156 10,47 2,48 109.145 1.151.107
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 139.875 -0,71
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 139.875 -0,71
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -500 546.500 -0,09
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -44.010 1.163.284 -3,65
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -18.500 6.911.334 -0,27
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 6,18 -6.185
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 6,18 -6.184
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500 0 -100,00 6,19 -3.097
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 420.146 -4,22 6,19 -114.461 2.599.485
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 438.646 4,40
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.655 420.146 -4,25 6,44 -120.168 2.706.412
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 44.010 438.801 11,15 2,48 109.145 1.088.226
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 140.875 -0,70
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 140.875 -0,70
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -500 547.000 -0,09
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -44.010 1.207.294 -3,52
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -18.500 6.929.834 -0,27
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 6,71 -6.706
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 6,71 -6.706
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500 0 -100,00 6,72 -3.358
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 394.791 -4,48 6,70 -123.896 2.643.955
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 413.291 4,69
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -17.336 394.791 -4,21 6,99 -121.175 2.759.510
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 44.010 412.127 11,96 2,48 109.145 1.022.075
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 141.875 -0,70
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 141.875 -0,70
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -500 547.500 -0,09
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -44.010 1.251.304 -3,40
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -18.500 6.948.334 -0,27
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 7,51 -7.512
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 7,51 -7.505
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500 0 -100,00 7,50 -3.750
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 368.117 -4,79 7,51 -138.874 2.763.344
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 386.617 5,03
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -16.017 368.117 -4,17 7,62 -121.989 2.803.653
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 44.010 384.134 12,94 2,48 109.145 952.652
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 142.875 -0,70
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 142.875 -0,70
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -500 548.000 -0,09
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -44.010 1.295.314 -3,29
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -18.500 6.966.834 -0,26
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 6,71 -6.712
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 6,71 -6.712
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500 0 -100,00 6,69 -3.347
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 340.124 -5,16 6,72 -124.355 2.286.280
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 358.544 5,44
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.420 340.124 -5,14 6,45 -118.864 2.194.820
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 44.010 358.544 13,99 2,48 109.145 889.189
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 143.875 -0,69
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 143.875 -0,69
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -500 548.500 -0,09
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -44.010 1.339.324 -3,18
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -18.500 6.985.334 -0,26
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 6,52 -6.522
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 6,51 -6.512
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500 0 -100,00 6,50 -3.248
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 314.534 -5,55 6,53 -120.792 2.053.687
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 333.034 5,88
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.218 314.534 -5,47 6,56 -119.446 2.062.242
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 44.010 332.752 15,24 2,48 109.145 825.225
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 144.875 -0,69
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 144.875 -0,69
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -500 549.000 -0,09
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -44.010 1.383.334 -3,08
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -18.500 6.985.334 -0,26
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 6,56 -6.561
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 6,57 -6.568
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500 0 -100,00 6,55 -3.277
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 288.742 -6,02 6,56 -121.434 1.895.302
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 307.242 6,41
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -17.326 288.742 -5,66 7,00 -121.279 2.021.136
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 44.010 306.068 16,79 2,48 109.145 759.049
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 145.875 -0,68
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.000 145.875 -0,68
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -500 549.500 -0,09
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -44.010 1.427.344 -2,99
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -18.500 7.003.834 -0,26
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 7,31 -7.309
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.000 0 -100,00 7,31 -7.309
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.000 1.000
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -500 0 -100,00 7,33 -3.666
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -18.500 262.058 -6,59 7,31 -135.176 1.914.805
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18.500 280.558 7,06
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -15.972 262.058 -5,74 7,58 -121.058 1.986.242
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 44.010 278.030 18,81 2,48 109.145 689.514
2022-03-15 2022-03-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion -6.150 7.022.334 -0,09
2022-03-15 2022-03-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale -6.150 234.020 -2,56 6,08 -37.407 1.423.427
2022-03-15 2022-03-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion 6.150 240.170 2,63
2022-03-15 2022-03-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion -230.000 7.028.484 -3,17
2022-03-15 2022-03-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale -230.000 234.020 -49,57 6,28 -1.444.814 1.470.067
2022-03-15 2022-03-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion 230.000 464.020 98,28
2022-03-15 2022-03-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion -100.000 7.258.484 -1,36
2022-03-15 2022-03-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale -100.000 234.020 -29,94 6,95 -694.580 1.625.456
2022-03-15 2022-03-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion 100.000 334.020 42,73
2022-03-09 2022-03-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion -300.000 7.358.484 -3,92
2022-03-09 2022-03-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale -300.000 234.020 -56,18 7,30 -2.188.950 1.707.527
2022-03-09 2022-03-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion 300.000 534.020 128,19
2022-02-24 2022-02-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion -100.000 7.658.484 -1,29
2022-02-24 2022-02-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale -100.000 234.020 -29,94 10,22 -1.021.540 2.390.608
2022-02-24 2022-02-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion 100.000 334.020 42,73
2022-02-08 2022-02-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 5.436 5.436
2022-02-08 2022-02-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 416.350 416.350
2022-02-08 2022-02-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes -343 234.020 -0,15 11,40 -3.910 2.667.828
2022-02-08 2022-02-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
A - Award 2.718 234.363 1,17
2022-02-08 2022-02-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
A - Award 208.175 231.645 886,98
2022-02-02 2022-01-31 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion -19.858 7.758.484 -0,26
2022-02-02 2022-01-31 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale -19.858 23.470 -45,83 11,73 -232.964 275.338
2022-02-02 2022-01-31 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion 19.858 43.328 84,61
2022-01-14 2022-01-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion -254.000 7.778.342 -3,16
2022-01-14 2022-01-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale -254.000 23.470 -91,54 13,57 -3.445.612 318.380
2022-01-14 2022-01-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion 254.000 277.470 1.082,23
2022-01-14 2022-01-13 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion -87.000 8.032.342 -1,07
2022-01-14 2022-01-13 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale -8.794 23.470 -27,26 14,96 -131.575 351.156
2022-01-14 2022-01-13 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale -78.206 32.264 -70,79 14,26 -1.114.991 459.991
2022-01-14 2022-01-13 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion 87.000 110.470 370,69
2022-01-14 2021-12-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
G - Gift -75.000 8.119.342 -0,92
2021-12-20 2021-12-16 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -200 8.194.342 0,00
2021-12-20 2021-12-16 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -200 23.470 -0,84 20,00 -4.001 469.517
2021-12-20 2021-12-16 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 200 23.670 0,85
2021-12-15 2021-12-13 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -100 8.194.542 0,00
2021-12-15 2021-12-13 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -100 23.470 -0,42 20,02 -2.002 469.752
2021-12-15 2021-12-13 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 100 23.570 0,43
2021-12-10 2021-12-09 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -1.086 8.194.642 -0,01
2021-12-10 2021-12-09 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -1.086 23.470 -4,42 20,01 -21.730 469.614
2021-12-10 2021-12-09 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1.086 24.556 4,63
2021-12-10 2021-12-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X -5.488 8.195.728 -0,07
2021-12-10 2021-12-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -28.646 1.471.354 -1,91
2021-12-10 2021-12-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -5.488 23.470 -18,95 20,26 -111.162 475.397
2021-12-10 2021-12-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 5.488 28.958 23,38
2021-12-10 2021-12-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X -5.176 23.470 -18,07 20,03 -103.670 470.081
2021-12-10 2021-12-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 28.646 28.646 2,47 70.756 70.756
2021-12-09 2021-12-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
S - Sale X -100 146.875 -0,07 21,07 -2.107 3.094.656
2021-12-09 2021-12-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
S - Sale X -3.025 146.975 -2,02 20,49 -61.994 3.012.076
2021-12-09 2021-12-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
S - Sale X -1.200 8.201.216 -0,01 21,06 -25.267 172.683.164
2021-12-09 2021-12-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
S - Sale X -15.467 8.202.416 -0,19 20,43 -316.065 167.614.730
2021-12-09 2021-11-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
G - Gift 550.000 550.000
2021-12-09 2021-11-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
G - Gift 550.000 550.000
2021-12-09 2021-11-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
G - Gift -1.100.000 8.217.883 -11,81
2021-04-22 2021-04-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
C - Conversion 1.500.000 1.500.000
2021-04-22 2021-04-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
C - Conversion -1.500.000 0 -100,00
2021-04-22 2021-04-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Series A-1 Preferred Stock
C - Conversion -32.685 0 -100,00
2021-04-22 2021-04-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Serie A Preferred Stock
C - Conversion -22.698 0 -100,00
2021-04-22 2021-04-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
J - Other 150.000 150.000
2021-04-22 2021-04-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Common Stock
J - Other -150.000 0 -100,00
2021-04-22 2021-04-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
J - Other 9.317.883 9.317.883
2021-04-22 2021-04-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Common Stock
J - Other -9.317.883 0 -100,00
2021-04-22 2021-04-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Common Stock
C - Conversion 55.383 9.317.883 0,60
2021-04-15 3 RXRX RECURSION PHARMACEUTICALS, INC.
Common Stock
9.262.500
2021-04-15 3 RXRX RECURSION PHARMACEUTICALS, INC.
Common Stock
150.000
P
Piața deschisă sau achiziția privată de titluri nederivate sau derivate
S
Piața deschisă sau vânzarea privată a titlurilor de valoare nederivate sau derivate
A
Acordarea, atribuirea sau alte achiziții de valori mobiliare de la companie (cum ar fi o opțiune)
C
Conversia derivatei
D
Vânzarea sau transferul de valori mobiliare înapoi către companie
F
Plata prețului de exercițiu sau a obligației fiscale folosind o parte din titlurile de valoare primite de la companie
G
Donarea de valori mobiliare de către sau către persoane din interior
K
Swap-uri de acțiuni și tranzacții similare de acoperire împotriva riscurilor
M
Exercitarea sau conversia titlurilor derivate primite de la companie (cum ar fi o opțiune)
V
O tranzacție raportată voluntar pe Formularul 4
J
Altele (însoțite de o notă de subsol care descrie tranzacția)